We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$243B
AUM Growth
+$27.2B
Cap. Flow
+$15.3B
Cap. Flow %
6.3%
Top 10 Hldgs %
14.51%
Holding
8,546
New
751
Increased
3,655
Reduced
3,101
Closed
634

Sector Composition

Rank Sector Weight
1 Financials 7.78%
2 Technology 7.19%
3 Healthcare 5.6%
4 Industrials 5.06%
5 Consumer Discretionary 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URGN icon
5301
UroGen Pharma
URGN
$2.28B
$102K ﹤0.01%
2,746
+1,746
+175% +$62.2K
EDZ icon
5302
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
$18M
$101K ﹤0.01%
222
+175
+372% +$87.8K
KN icon
5303
Knowles
KN
$3.45B
$101K ﹤0.01%
6,887
-11,090
-62% -$173K
TITN icon
5304
Titan Machinery
TITN
$456M
$101K ﹤0.01%
4,766
-319
-6% -$5.49K
TTI icon
5305
TETRA Technologies
TTI
$1.28B
$101K ﹤0.01%
23,683
-7,165
-23% -$24.7K
TA
5306
DELISTED
TravelCenters of America LLC
TA
$101K ﹤0.01%
4,932
+1,836
+59% +$42.6K
VCRA
5307
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$101K ﹤0.01%
3,353
-118
-3% -$3.36K
UBIO
5308
DELISTED
Proshares UltraPro NASDAQ Biotechnology
UBIO
$101K ﹤0.01%
+3,003
New +$103K
CBPX
5309
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
$101K ﹤0.01%
3,592
+489
+16% +$13.2K
CZR
5310
DELISTED
Caesars Entertainment Corporation
CZR
$101K ﹤0.01%
+8,009
New +$102K
ATOM icon
5311
Atomera
ATOM
$213M
$100K ﹤0.01%
23,011
-23,445
-50% -$85.6K
BTI icon
5312
PUT
British American Tobacco
BTI
$127B
$100K ﹤0.01%
+1,500
New +$97.8K
CLDX icon
5313
Celldex Therapeutics
CLDX
$3.24B
$100K ﹤0.01%
2,358
-2,733
-54% -$117K
OPY icon
5314
Oppenheimer Holdings
OPY
$1.24B
$100K ﹤0.01%
3,747
+852
+29% +$20.1K
FAIL
5315
DELISTED
Cambria Global Tail Risk ETF
FAIL
$100K ﹤0.01%
+3,605
New +$101K
DCPH
5316
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$100K ﹤0.01%
+4,407
New +$86.3K
ZJPN
5317
DELISTED
SPDR Solactive Japan ETF
ZJPN
$100K ﹤0.01%
1,266
-328
-21% -$25.4K
CENX icon
5318
Century Aluminum
CENX
$4.78B
$99K ﹤0.01%
5,036
+4,492
+826% +$68.8K
HFRO
5319
Highland Opportunities and Income Fund
HFRO
$408M
$99K ﹤0.01%
+6,407
New +$98.4K
VBFC
5320
DELISTED
Village Bank and Trust Financial Corp.
VBFC
$99K ﹤0.01%
3,223
+376
+13% +$11.5K
PRFT
5321
DELISTED
Perficient Inc
PRFT
$99K ﹤0.01%
5,181
+797
+18% +$15.4K
ASXC
5322
DELISTED
Asensus Surgical, Inc.
ASXC
$99K ﹤0.01%
3,965
+3,773
+1,965% +$116K
NXGN
5323
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$99K ﹤0.01%
7,293
-736
-9% -$10.6K
RETA
5324
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$99K ﹤0.01%
3,475
+1,110
+47% +$31K
WVFC
5325
DELISTED
WVS Financial Corp
WVFC
$99K ﹤0.01%
6,375
-314
-5% -$4.86K

Similar funds

UBS Group's Q4 2017 Portfolio in Review

As of Q4 2017, UBS Group held 8,546 positions worth $243B, up 13% from $216B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group deployed $15.3B of net new capital in Q4 2017, opening 751 new positions and adding to 3,655 existing holdings. Its largest new stake was Columbia Diversified Fixed Income Allocation ETF: 857,912 shares worth $17.1M.

By sector, the portfolio is most concentrated in Financials at 7.8% of assets, up from 7.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $4.22B trimmed.

  • UBS Group's largest Q4 2017 buy was Columbia Diversified Fixed Income Allocation ETF: 857,912 shares worth $17.1M.
  • UBS Group added most to Apple in Q4 2017, an estimated $602M increase.
  • UBS Group's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.22B.
  • UBS Group fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $139M.
  • UBS Group's ten largest holdings make up 15% of its $243B portfolio in Q4 2017.
  • UBS Group opened 751 new positions and closed 634 in Q4 2017.
  • UBS Group's portfolio value rose 13% quarter-over-quarter to $243B.

Based on UBS Group's 13F filing for Q4 2017, filed 14 Feb 2018.